Why Eating Disorder Therapy Fails: Improving Treatment Retention & Engagement

The challenge of keeping patients engaged in eating disorder treatment is a significant hurdle, despite advances in effective therapies. Prematurely ending therapy not only diminishes the chances of recovery for individuals but also represents a strain on clinical resources. Understanding why patients discontinue treatment is shifting from a focus on individual motivation to a broader examination of treatment characteristics and the organization of care itself.

The Complex Landscape of Treatment Discontinuation

Researchers are increasingly recognizing that dropping out of treatment isn’t simply a failure of willpower on the patient’s part. Instead, it’s a signal – a complex indicator that something about the treatment process isn’t working for that individual. A recent perspective published in the International Journal of Eating Disorders by Tracey Wade and Ulrike Schmidt highlights five key categories of treatment discontinuation, offering a more nuanced understanding of this pervasive problem.

The first, and perhaps most commonly considered, is patient-initiated dropout. This can stem from a variety of factors. Some treatments, particularly cognitive behavioral therapy (CBT), demand significant effort and early behavioral changes, which can feel overwhelming. The nature of eating disorders themselves can also play a role; the “ego-syntonic” quality – where the disorder feels integrated into one’s identity and even provides a sense of control or emotional regulation – can make it difficult to relinquish behaviors. Patients may also feel their needs aren’t being met or that the therapeutic approach isn’t a fine fit. A strong therapeutic alliance, built on collaboration and shared goals, is crucial for retention.

However, discontinuation isn’t always a patient choice. Therapist-initiated discontinuation occurs when a patient’s behavior actively hinders the therapeutic process – repeated cancellations, consistent lateness, or a lack of engagement with assigned tasks. A third category involves ending therapy early, but with mutual agreement between therapist and patient, when stable remission has been achieved. This is less common than premature dropout. A fourth, more concerning, scenario is discontinuation due to clinical deterioration, often requiring a shift to more intensive care, such as hospitalization, particularly in cases of anorexia nervosa where medical risks escalate. Finally, logistical reasons – relocation, illness, or changes in insurance – can also interrupt treatment.

Dropout Rates and Risk Factors

Data suggests that approximately 24% of individuals undergoing cognitive behavioral therapy (CBT) for eating disorders discontinue treatment. However, dropout rates are notably higher – ranging from 25% to 44% – in treatments specifically for anorexia nervosa. These rates appear even higher in real-world clinical settings. Interestingly, adolescents and young adults tend to have lower dropout rates, likely due to greater family involvement.

Certain factors present at the start of therapy are associated with a higher risk of discontinuation, although the evidence isn’t always consistent. These include more severe eating disorder symptoms, rigid dietary restraint, low motivation for change, older age, a history of trauma, difficulties with executive functioning (planning, organization, impulse control), co-occurring psychiatric conditions, and lower self-efficacy – a belief in one’s ability to succeed. The Mayo Clinic highlights the importance of addressing any co-existing medical problems that an eating disorder may cause or worsen, as these can also contribute to treatment interruption. Learn more about comprehensive eating disorder treatment options at the Mayo Clinic.

Waiting times also play a critical role. Prolonged waiting lists before treatment begins are linked to higher dropout rates. Research during the COVID-19 pandemic demonstrated that increased waiting times correlated with more treatment discontinuation, while reduced waiting times led to improved retention. This suggests that a patient’s motivation can wane during extended periods of uncertainty.

Strategies for Improved Engagement

Maintaining contact with patients while they are on waiting lists can help sustain their engagement and increase the likelihood of starting and continuing treatment. Brief informational sessions, psychoeducational materials, guided self-help programs, and digital tools can all be valuable resources during this period. The Academy for Eating Disorders offers a range of treatment options and resources to support both patients and clinicians.

Coordinated multidisciplinary care – integrating psychotherapy with nutritional counseling and collaboration among healthcare professionals – is another promising strategy. Recovery-oriented support interventions, such as sharing recovery stories or providing mentorship from former patients, can also bolster motivation. Allowing patients some choice in their treatment plan can enhance their sense of ownership and reduce the likelihood of dropout. Regular monitoring of treatment progress, with feedback to both patient and therapist, allows for early identification of difficulties and adjustments to the approach.

Personalization and the Therapeutic Relationship

Greater attention to personalizing treatment and fostering a strong therapeutic relationship are also key. A supportive and collaborative environment, where patients feel understood and respected, is essential for building trust and maintaining engagement. This requires therapists to be attuned to individual needs and preferences, and to adapt their approach accordingly.

Looking Ahead: A Shift in Perspective

Addressing premature treatment discontinuation requires a fundamental shift in perspective. Rather than viewing dropout solely as a patient “problem,” it’s crucial to recognize it as an opportunity to evaluate and improve treatment delivery and service organization.

Better management of waiting lists, interventions to strengthen patient engagement, and a heightened focus on the therapeutic relationship are all essential components of a more effective system of care. Reducing treatment interruptions isn’t just about improving statistics; it’s about increasing the chances that more individuals with eating disorders can complete therapy and achieve lasting recovery. Further research is needed to refine these strategies and to identify additional factors that contribute to treatment discontinuation, paving the way for more personalized and effective care.